Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular transformation by human T-cell leukemia virus type I

S Ressler1, L M Connor, S J Marriott

  • 1Division of Molecular Virology, Baylor College of Medicine, Houston, TX 77030, USA.

FEMS Microbiology Letters
|July 1, 1996
PubMed
Summary

Human T-cell leukemia virus type I (HTLV-I) causes adult T-cell leukemia by its Tax protein. Tax transforms cells by continuously activating growth-promoting genes, leading to uncontrolled proliferation and cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2009
Same author

WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection.

Journal of virology·2007
Same author

Overexpression of p101 activates PI3Kgamma signaling in T cells and contributes to cell survival.

Oncogene·2007
Same author

Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence.

Experimental gerontology·2006

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Background:

  • Human T-cell leukemia virus type I (HTLV-I), identified in 1980, is a known oncogenic retrovirus.
  • HTLV-I is etiologically linked to adult T-cell leukemia/lymphoma (ATLL).

Purpose of the Study:

  • To elucidate the molecular mechanisms by which HTLV-I induces cellular transformation.
  • To identify the specific viral component responsible for the oncogenic potential of HTLV-I.

Main Methods:

  • Experiments involving HTLV-I infected T-cells.
  • Studies utilizing transgenic mouse models.
  • In vitro tissue culture transformation assays.

Main Results:

  • The Tax protein of HTLV-I was identified as the primary transforming factor.

Related Experiment Videos

  • Tax protein mediates transformation by transcriptionally regulating cellular genes.
  • These regulated genes are critical for cell growth and proliferation.

    • Conclusions:

    • The Tax protein is the key oncogenic component of HTLV-I.
    • Unregulated activation of growth-related genes by Tax leads to uncontrolled cell proliferation.
    • This sustained activation by Tax is the ultimate cause of HTLV-I-induced transformation and cancer.